Altria Group, Inc. (NYSE: MO) Price Prediction and Forecast 2025-2030 (November 2025)

Altria Group (MO) recently saw its stock decline by 14.25% over the past month, despite reporting Q3 adjusted EPS of $1.45, exceeding analyst expectations, and narrowing its full-year 2025 EPS guidance to $5.37-$5.45. The Dividend King, currently yielding 7.52%, also expanded its share repurchase program to $2 billion. Strategic moves, including the acquisition of vape maker NJOY and investments in cannabis and oral nicotine pouches, position Altria to capitalize on growing demand in smokeless product segments. Analysts maintain a consensus 'Hold' rating with a one-year price target of $64.50, anticipating that the company's high dividend and low P/E will continue to attract investors.

Analysis

Altria Group (MO) experienced a significant stock decline, plummeting 14.25% over the past month and down 7.37% year-to-date in 2025, despite reporting Q3 adjusted EPS of $1.45, which exceeded analyst expectations. This sell-off was primarily attributed to a 3% year-over-year decline in total revenue, driven by lower sales in its smokeable and oral tobacco segments.

The company is strategically pivoting towards non-combustible products, evidenced by its acquisition of vape maker NJOY, which provides access to a massive distribution network and secured the first FDA marketing orders for menthol e-vapor products. Investments in Helix (oral nicotine pouches) and Cronos (cannabis) further underscore this shift, aiming to capitalize on the smokeless product industry's projected 4.8% CAGR from 2024 to 2030.

Altria maintains its appeal to income investors as a Dividend King, currently offering a 7.52% yield and having increased its distribution 60 times over 56 years. The company also expanded its share repurchase plan to $2 billion through December 2026, reinforcing its commitment to shareholder returns and providing support amidst market volatility.

Analyst consensus holds a "Hold" rating for MO, with a one-year price target of $64.50, representing a potential 14.40% upside. This outlook is supported by the company's high dividend yield and relatively low P/E ratio, which are expected to attract investors despite ongoing market downturns and competitive pressures from products like ZYN nicotine pouches.

Key Decisions for Investors

• Investors should closely monitor Altria's progress in expanding its non-combustible product portfolio, particularly the market penetration and revenue contribution of NJOY and Helix, as these are critical for future growth amidst declining traditional tobacco sales.
• Evaluate the sustainability of Altria's dividend growth and share repurchase program, as these capital return policies are key drivers for its institutional investor base and provide a floor for the stock price.
• Consider the competitive landscape and regulatory developments in the smokeless and cannabis markets, including FDA approvals for rival products, which could impact Altria's long-term market share and strategic positioning.